Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
6.92
+0.29 (4.37%)
Jul 10, 2026, 3:45 PM EDT - Market open
Cybin Employees
Cybin had 100 employees as of March 31, 2026. The number of employees increased by 50 or 100.00% compared to the previous year.
Employees
100
Change (1Y)
50
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,479,980
Market Cap
428.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 100 | 50 | 100.00% |
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| Puma Biotechnology | 179 |
| Lyell Immunopharma | 161 |
| Adlai Nortye | 109 |
| Foghorn Therapeutics | 106 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
HELP News
- 1 day ago - Psychedelic: Compass Pathways reports six-month data for psilocybin drug - TheFly
- 1 day ago - Helus Pharma price target lowered to $70 from $95 at H.C. Wainwright - TheFly
- 9 days ago - Helus Pharma price target lowered to $42 from $45 at Canaccord - TheFly
- 11 days ago - Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results - GlobeNewsWire
- 11 days ago - Cybin Annual report: Q4 2026 - Filings
- 11 days ago - Cybin Earnings release: Q4 2026 - Filings
- 11 days ago - Cybin Slides: Corporate presentation - Filings
- 15 days ago - Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering - GlobeNewsWire